Another study found that BBB-associated pericytes cleared Aβ aggregation through LRP1/APOE subtype-specific mechanisms, supporting the role of the LRP1/APOE interaction as a potential therapeutic target for controlling Aβ clearance in AD (Ma et al., 2018). This evidence concerns the gene LRP1 and Alzheimer disease.